Affimed N.V. Skyrocketed
Fri, Apr 09, 2021 at 05:30 PM
Affimed N.V. (AFMD:NASDAQ) jumped higher at $9.74, representing a gain of 23.4%. The stock appeared on our News Catalysts scanner on Fri, Apr 09, 2021 at 10:33 AM in the 'BIOTECH' category. From Thu, Mar 25, 2021, the stock recorded 44.44% Up Days and 40.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About Affimed N.V. (AFMD:NASDAQ)
Affimed NV is a clinical-stage biopharmaceutical company. It is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology to fight tumor cells.
Top 10 Gainers:
- Alta Equipment Group Inc. (BRPM:NYSE), 100%
- Celcuity Inc. (CELC:NASDAQ), 50.94%
- REPX (REPX:NYSEMKT), 29.83%
- Lineage Cell Therapeutics, Inc. (BTX:NYSEMKT), 25.1%
- Affimed N.V. (AFMD:NASDAQ), 23.45%
- China Green Agriculture, Inc. (CGA:NYSE), 22.59%
- BCTX (BCTX:NASDAQ), 18.95%
- CLVR (CLVR:NASDAQ), 18.31%
- Tenax Therapeutics, Inc. (TENX:NASDAQ), 16.85%
- UTME (UTME:NASDAQ), 15.96%